Science Current Events | Science News | Brightsurf.com
 

Tamoxifen Current Events | Tamoxifen News

Page 1 of 4 | 88 Results
Previous01020304   Next   
Sort By: Page Views | Date
Potential dangers of long term tamoxifen use
Tamoxifen prolongs the life of women with breast cancer and may significantly reduce the risk of developing the disease in those with an inherited tendency. But, suggests a leading article in the Journal of Clinical Pathology, long term use may produce other serious abnormalities, including cancer.   view more (1999-02-12)

Further breakthroughs for breast cancer patients
Researchers at the Tenovus Centre for Cancer Research at Cardiff University have made a breakthrough in breast cancer treatment that could help save the lives of women who become resistant to breast cancer drugs such as tamoxifen.   view more (2008-01-21)

Chemotherapy and tamoxifen reduce risk of second breast cancer
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5... view more (2007-12-26)

TAMOXIFEN FOR PREVENTION OF BREAST CANCER - ENCOURAGING RESULTS BUT RISKS STILL UNCLEAR (pp 813, 817)
Early findings from a randomised trial investigating the effectiveness of tamoxifen to prevent breast cancer are reported in this week’s issue of THE LANCET. Although tamoxifen reduced breast cancer incidence by a third compared with women given placebo, the authors of the study caution that... view more (2002-09-11)

Early Promise Of Alternative Hormone Treatment For Breast Cancer
A fast-track study in this week's issue of THE LANCET suggests that the drug anastrozole could be an effective option for the treatment of postmenopausal women with hormone-sensitive early breast cancer. Tamoxifen therapy for five years after surgery is the established treatment for postmenopausal... view more (2002-06-19)

Tamoxifen chemoprevention tied to early detection of breast cancer
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute.   view more (2008-10-08)

Herbal Menopause Therapy a Good Fit for Breast Cancer Patients?
When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a... view more (2008-10-08)

Ireland Cancer Center researcher finds standard treatment for breast cancer not followed
Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment -... view more (2007-12-26)

Gene variation affects tamoxifen's benefit for breast cancer
One of the most commonly prescribed drugs for breast cancer, tamoxifen, may not be as effective for women who inherit a common genetic variation, according to researchers at the University of Michigan and the Mayo Clinic.   view more (2005-12-19)

New research shows no link between aromatase inhibitors and cardiovascular problems
New evidence has emerged that, contrary to some current fears, aromatase inhibitors (AIs) are not associated with an increased risk of heart problems in women who take them to prevent their breast cancer recurring.   view more (2008-04-17)

Researchers Discover Method in Mice to Restore Tamoxifen Sensitivity in Resistant Breast Cancer
The widely used breast cancer drug tamoxifen (Nolvadex®), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug, according to new research in mice conducted by investigators from the National Cancer Institute (NCI), part of the... view more (2006-12-21)

First IBIS results show tamoxifen reduces breast cancer in healthy high-risk women
First results from the long-awaited IBIS trial into the use of tamoxifen to prevent breast cancer in healthy women at high risk have firmly established that the drug can indeed cut the incidence of the disease. These preliminary results were presented today (Wednesday 20 March) at the 3rd European... view more (2002-03-19)

Combining therapies can improve survival for early-stage breast cancer patients
Patients with early-stage breast cancer who are treated with both chemotherapy and tamoxifen have a higher survival rate than patients who receive only tamoxifen.   view more (2007-04-04)

Radiotherapy Best Option After Surgery For Ductal Carcinoma In Situ (p 95)
UK research published in this week's issue of THE LANCET suggests that women with a pre-invasive cancer of the breast known as ductal carcinoma in situ (DCIS) are less likely to progress to invasive cancer if they are given radiotherapy after surgery. Mammographic breast screening (introduced in... view more (2003-07-09)

'Arimidex' (anastrozole) significantly reduces the risk of contralateral breast tumours compared to gold-standard tamoxifen
Latest results from the ATAC (Arimidex, Tamoxifen Alone or in Combination) study in early breast cancer, presented today at the 3rd European Breast Cancer Conference (EBCC), show that treatment with 'Arimidex' more than halved the risk of post-menopausal women developing new tumours in the other... view more (2002-03-21)

Letrozole following tamoxifen may benefit women with breast cancer
Switching to the drug letrozole following 5 years of treatment with tamoxifen reduces the risk of hormone-dependent breast cancer recurrence, but not overall survival, among postmenopausal women.   view more (2005-09-07)

New evidence eases some concerns about bone fracture risk with breast cancer drug
Copenhagen, Denmark: New evidence about the breast cancer drug anastrozole (Arimidex) shows that the incidence of a major side-effect - bone fractures - appears to stabilise after reaching a peak at two years of treatment, easing some of the concerns about the drug. This finding is the latest to... view more (2003-09-21)

Exemestane beats tamoxifen in first phase III head to head trial in advanced breast cancer
Hamburg, Germany: The first results from the world's only phase III trial to compare tamoxifen with the newer hormone treatment exemestane in advanced breast cancer shows that exemestane is safe, superior and lengthens progression-free survival. The median progression-free survival for patients... view more (2004-03-16)

Benefit of chemotherapy in breast cancer depends on estrogen-receptor status
When it comes to chemotherapy treatment for women whose breast cancer has spread to their lymph nodes, the estrogen status of their tumors matters.   view more (2006-04-12)

New role for tamoxifen as fertility drug for breast cancer patients?
US fertility experts have discovered a potential new role for the wonder drug tamoxifen - helping breast cancer patients to have babies by IVF. In a study published today (Wednesday 8 January) in Europe's leading reproductive medicine journal Human Reproduction [1], researchers from New York's... view more (2003-01-03)

Manic phase of bipolar disorder benefits from breast cancer medication
The medication tamoxifen, best known as a treatment for breast cancer, dramatically reduces symptoms of the manic phase of bipolar disorder more quickly than many standard medications for the mental illness, a new study shows.   view more (2007-09-12)

Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen
Acupuncture provides effective relief from hot flushes in women who are being treated with the anti-oestrogen tamoxifen following surgery for breast cancer, according to new research presented today (Friday) at the 6th European Breast Cancer Conference (EBCC-6) in Berlin.   view more (2008-04-18)

Hormone drug type makes survival difference in advanced breast cancer
Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.   view more (2007-01-31)

Leading cancer doctor calls for new guidelines to control early reporting from clinical trials
Hamburg, Germany: A leading breast cancer doctor is urging researchers to consider changing the guidelines that govern whether clinical trials should be stopped prematurely, as she believes that current practice could be damaging research efforts. Dr Martine Piccart, head of the chemotherapy unit... view more (2004-03-16)

Researchers say estrogen can kill breast cancer cells once fueled by the hormone
Fox Chase Cancer Center researchers say some breast cancer cells once fueled by estrogen can be killed by the same hormone.   view more (2005-12-07)
Page 1 of 4 | 88 Results
Previous01020304   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com